The most important trend forecast by pharmaceutical experts is the continuing, worldwide increasing demand for biological drugs and biosimilars. With the recently founded, Gx Biological Solutions organization, Gerresheimer has installed a dedicated team to serve the highly specific requirements in the biological play field.
The global biopharmaceuticals market is driven by various factors, such as the increase in the elderly population, surge in the prevalence of chronic diseases like cancer and diabetes, and growth in the adoption of biopharmaceuticals globally. Furthermore, a rise in strategic collaborations among biopharmaceuticals companies is also anticipated to supplement the growth of the biopharmaceutical industry.
Biological drugs are specifically being used to treat, for example, rheumatism, diabetes, or cancer and are usually administered parenterally. They differ from conventional drugs in their molecular structure. Hence special demands on the primary packaging are to be taken care of. Gerresheimer has developed a complete package of services and products for these biological drugs and biosimilars. This includes a dedicated, innovative product portfolio consisting of specialty syringes and vials, safety devices, and more that meet the specific requirements of this continuously growing market segment. At the same time, Gerresheimer also offers a wide range of services, especially for small and medium-sized biotech companies. Whether it is advised on the right primary packaging to be used in the appropriate clinical phase or support with approval and regulatory processes, lab services, and much more.
Gx Biological Solutions – new founded team of specialists
At Pharmapack 2020 in Paris, Gerresheimer has presented its products for the safe, innovative and sustainable packaging of biologicals. “We want to offer our customers in the pharmaceutical industry with customized packaging solutions for their biologics so that they can be assured that all of their requirements are met 100%,” said Stefan Verheyden, Global vice president of Gx Biological Solutions team.
Small Batch Production in Germany
As a leading manufacturer of syringes, injection vials as well as cartridges and administration systems, Gerresheimer covers a very broad spectrum for the parenteral administration of biologicals within its portfolio. Smaller batch sizes are often requested when filling biological products. Hence Gerresheimer has invested in a small batch production facility in Wackersdorf – Germany. When the filled biological agent is sensitive to its storage environment, the container must be individually adapted to its properties. During the clinical development phase, Gerresheimer experts can support with advice on the right primary packaging, syringe, or drug delivery device, as well as with regulatory approval processes and much more.
